Theseus Pharmaceuticals Statistics

Total Valuation

THRX has a market cap or net worth of $1.14 billion. The enterprise value is $1.25 billion.

Market Cap	1.14B
Enterprise Value	1.25B

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	57.98M

Valuation Ratios

The trailing PE ratio is 48.95.

PE Ratio	48.95
Forward PE	n/a
PS Ratio	3.19
Forward PS	n/a
PB Ratio	1.66
P/TBV Ratio	2.46
P/FCF Ratio	6.08
P/OCF Ratio	6.07
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.03, with an EV/FCF ratio of 6.65.

EV / Earnings	53.57
EV / Sales	3.49
EV / EBITDA	6.03
EV / EBIT	6.94
EV / FCF	6.65

Financial Position

The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.75.

Current Ratio	2.35
Quick Ratio	2.11
Debt / Equity	0.75
Debt / EBITDA	2.50
Debt / FCF	2.76
Interest Coverage	8.14

Financial Efficiency

Return on equity (ROE) is 3.42% and return on invested capital (ROIC) is 9.39%.

Return on Equity (ROE)	3.42%
Return on Assets (ROA)	8.88%
Return on Invested Capital (ROIC)	9.39%
Return on Capital Employed (ROCE)	16.97%
Revenue Per Employee	$2.82M
Profits Per Employee	$184,189
Employee Count	127
Asset Turnover	0.28
Inventory Turnover	0.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.91% in the last 52 weeks. The beta is 3.98, so THRX's price volatility has been higher than the market average.

Beta (5Y)	3.98
52-Week Price Change	-63.91%
50-Day Moving Average	3.96
200-Day Moving Average	4.94
Relative Strength Index (RSI)	59.85
Average Volume (20 Days)	551,970

Short Selling Information

The latest short interest is 401,675, so 0.92% of the outstanding shares have been sold short.

Short Interest	401,675
Short Previous Month	527,466
Short % of Shares Out	0.92%
Short % of Float	2.82%
Short Ratio (days to cover)	10.70

Income Statement

In the last 12 months, THRX had revenue of $358.71 million and earned $23.39 million in profits. Earnings per share was $0.36.

Revenue	358.71M
Gross Profit	322.28M
Operating Income	180.69M
Pretax Income	37.39M
Net Income	23.39M
EBITDA	206.72M
EBIT	180.69M
Earnings Per Share (EPS)	$0.36

Full Income Statement

Balance Sheet

The company has $412.50 million in cash and $520.63 million in debt, giving a net cash position of -$108.13 million.

Cash & Cash Equivalents	412.50M
Total Debt	520.63M
Net Cash	-108.13M
Net Cash Per Share	n/a
Equity (Book Value)	691.16M
Book Value Per Share	11.03
Working Capital	318.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $188.69 million and capital expenditures -$270,000, giving a free cash flow of $188.42 million.

Operating Cash Flow	188.69M
Capital Expenditures	-270,000
Free Cash Flow	188.42M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 89.84%, with operating and profit margins of 50.37% and 6.52%.

Gross Margin	89.84%
Operating Margin	50.37%
Pretax Margin	10.42%
Profit Margin	6.52%
EBITDA Margin	57.63%
EBIT Margin	50.37%
FCF Margin	52.53%

Dividends & Yields

THRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.04%
FCF Yield	16.46%

Analyst Forecast

Price Target	n/a
Price Target Difference	189.41%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

THRX has an Altman Z-Score of 2.09 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.09
Piotroski F-Score	3